Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jouni Silvennoinen"'
Autor:
Ilkka Vihriälä, Jari Punkkinen, Tero Ylisaukko-oja, Taina Sipponen, Eija Hirsi, Christian Nielsen, Jyrki Tillonen, Markku Pajala, Jouni Silvennoinen, Ville Liukkonen, Mikko Kellokumpu, Jari Jokelainen, Henna Rautiainen, Veikko Moilanen, Hans Henricson, Hannu Sulonen, Mirva Esterinen, Timo Blomster, Kari Toljamo, Klaus Tamminen, Pauliina Molander, Airi Jussila, Jaakko Aaltonen, Juha Kuisma, Petri Mäkelä, Kalle Hakala, Margus Lääne, Kimmo Salminen, Sauli Herrala, Ulla-Maija Suhonen, Mika Puhto, Markku Peräaho, Heikki Nuutinen
Publikováno v:
Scandinavian Journal of Gastroenterology. 53:158-167
Objectives: The efficacy and tolerability of vedolizumab in the treatment of inflammatory bowel diseases (IBD) has been demonstrated in an extensive GEMINI clinical trial programme. Clinical trials represent highly selected patient populations and, t
Autor:
Klaus Tamminen, Mikko Kellokumpu, Tero Ylisaukko-oja, Sauli Herrala, Markku Peräaho, Taina Sipponen, Henna Rautiainen, Petri Mäkelä, Jari Jokelainen, Ulla-Maija Suhonen, Heikki Nuutinen, Markku Pajala, Mirva Esterinen, Margus Lääne, Mika Puhto, Christian Nielsen, Jyrki Tillonen, Veikko Moilanen, Juha Kuisma, Ville Liukkonen, Kalle Hakala, Pauliina Molander, Hannu Sulonen, Saku Torvinen, Jaakko Aaltonen, Jouni Silvennoinen, Hans Henricson, Ilkka Vihriälä, Eija Hirsi, Kari Toljamo, Airi Jussila, Jari Punkkinen, Timo Blomster, Kimmo Salminen
Publikováno v:
Biologicals : journal of the International Association of Biological Standardization. 58
Limited data is available on vedolizumab combination therapies in real-world clinical practice. Here, we evaluated the concomitant corticosteroid, immunosuppressive, and 5-aminosalicylic acid utilization of inflammatory bowel disease (IBD) patients t
Autor:
Henning Adamek, Norbert Börner, Marco Oudkerk Pool, Michael Mross, Axel Dignass, Henri Veerman, Bernd Bokemeyer, Lars Vinter-Jensen, Theo Stijnen, Gie Tan, Peter Dietel, T. Klugmann, Severine Vermeire, Jouni Silvennoinen, Aomesh Bhatt
Publikováno v:
Clinical Gastroenterology and Hepatology. 7:762-769
Oral mesalamine (5-aminosalicylate) is the current standard of care for mild-to-moderate ulcerative colitis. We investigated the efficacy and safety of once daily administration of prolonged-release mesalamine granules in maintenance of remission in
Autor:
Kari Hakkinen, Jouni Silvennoinen
Publikováno v:
Technology, Law and Insurance. 3:3-10
Industrial accidents and failures involving machinery were analysed by appropriate literature and loss records of insurers. While serious machinery accidents have decreased for many types of machinery, thanks to developments in technologies and safet
Publikováno v:
Journal of Internal Medicine. 240:285-292
Objectives. To investigate calcium intake and its association with bone mineral density (BMD) and the type and extent of the disease in patients with inflammatory bowel disease (IBD). Setting. University hospital clinic. Subjects. A total of 152 unse
Autor:
Jouni Silvennoinen, Vinciane Muls, Per Broberg, Marco Oudkerk Pool, Ragnar Befrits, Milan Lukas, Axel Dignass
Publikováno v:
Gastroenterology. 138:S-520
Autor:
H.E. Adamek, Michael Mross, Henri Veerman, N. Boerner, Jouni Silvennoinen, Axel Dignass, Lars Vinter-Jensen, Theo Stijnen, Bernd Bokemeyer, M. Oudkerk-Pool, T.G. Tan, Peter Dietel, T. Klugmann
Publikováno v:
Gastroenterology. 134:A-495
Autor:
H.E. Adamek, Peter Dietel, Michael Mross, Bernd Bokemeyer, T. Klugmann, Henri Veerman, M. Oudkerk-Pool, Theo Stijnen, Lars Vinter-Jensen, T.G. Tan, Axel Dignass, N. Boerner, Jouni Silvennoinen
Publikováno v:
Gastroenterology. 134:A-494
Autor:
Jouni Silvennoinen, Henry Nyhlin, Christen Bang, Maghild Berge, Peter C. Rueegg, Lars Elsborg, Ingar Holme, Amy Wagner, Julie Jones
Publikováno v:
Gastroenterology. 124:A389